Abbott Laboratories ABT:NYSE (Common Stock)

LastDaily Change / % ChangeDividend YieldVolumeAvg Volume (10 day)
59.31 0.24   0.41%1.89%7,363,0085.9M
Market data is delayed by at least 15 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Previous close 1/19/2018

Latest News Headlines for Abbott Laboratories

No News for Abbott Laboratories

Peers Information HelpABT Abbott Laboratories vs. Peers

Abbott Laboratories
Eli Lilly and Co
Bristol-Myers Squibb Co
AstraZeneca plc (ADR)
Novo Nordisk A/S (ADR)
Abbott Laboratories
Eli Lilly and Co
Bristol-Myers Squibb Co
AstraZeneca plc (ADR)
Novo Nordisk A/S (ADR)
Abbott Laboratories
Eli Lilly and Co
Bristol-Myers Squibb Co
AstraZeneca plc (ADR)
Novo Nordisk A/S (ADR)
Compare these stocks

Latest Annual and Quarterly SEC Filings

More Filings

This report contains detailed information about the company's business finances and management.


Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.


expand, down-facing arrow indicating expanded view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open59.23
Previous Close59.07
Day High59.68
Day Low58.96
52 Week High1/19/2018 | 59.68
52 Week Low1/25/2017 | 39.25
% Off 52 Week High-0.62%
% Off 52 Week Low51.11%
Beta (5 Yr)1.5
Volatility Avg1/19/2018 | 13.82
10-Day Avg. Volume5,917,598
Market data is delayed by at least 15 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)9/30/2017 | 1.21
P/E Ratio9/30/2017 | 48.9
Market CapLarge Cap | 103.24B
Shares Outstanding1.74B

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield1.89%
Dividend Announcement12/15/2017
Date of Record1/12/2018
Payable$0.28 - QRTR
Payable Date2/15/2018

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short9.79M
Short Ratio1.7
Short % of Float0.57%
As of 12/29/2017
The performance data quoted represents past performance. Past performance does not guarantee future results. Current performance may be lower or higher than the performance quoted. Investment return and principal value of an investment will fluctuate and when redeemed, the investment may be worth more or less than their original cost.
The research, tools, and information provided will not include every security available to the public.